ORAL SALMONELLA - MALARIA CIRCUMSPOROZOITE RECOMBINANTS INDUCE SPECIFIC CD8+ CYTOTOXIC T-CELLS

被引:193
作者
AGGARWAL, A
KUMAR, S
JAFFE, R
HONE, D
GROSS, M
SADOFF, J
机构
[1] WALTER REED ARMY MED CTR, DEPT BACTERIAL DIS, WASHINGTON, DC 20307 USA
[2] SK&F LABS, DEPT MOLEC GENET, SWEDELAND, PA 19406 USA
[3] UNIV MARYLAND, SCH MED, CTR VACCINE DEV, BALTIMORE, MD 21201 USA
[4] NIAID, PARASIT DIS LAB, BETHESDA, MD 20892 USA
关键词
D O I
10.1084/jem.172.4.1083
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oral immunization with an attenuated Salmonella typhimurium recombinant containing the fulllength Plasmodium berghei circumsporozoite (CS) gene induces protective immunity against P. berghei sporozoite challenge in the absence of antibody. We found that this immunity was mediated through the induction of specific CD8+ T cells since in vivo elimination of CD8+ cells abrogated protection. In vitro studies revealed that this Salmonella-P. berghei CS recombinant induced class I-restricted CD8+ cytotoxic T cells that are directed against the P berghei CS peptide epitope spanning amino acids 242-253. This is the same peptide that previously was identified as the target of cytotoxic T lymphocytes (CTL) induced by sporozoite immunization. Salmonella-P.fkiparum CS recombinants were constructed that contained either the full-length CS gene or a repeatless gene consisting of CS flanking sequences. Both of these vaccines were able to induce CD8+ CTL directed against P. fakiparum CS peptide 371-390, which is identical to the target of CTL induced by sporozoites and vaccinia CS recombinants. These results directly demonstrate the ability of an intracellular bacteria such as Salmonella to induce class I-restricted CD8+ CTL and illustrate the importance of CD8+ CTL in immunity to malaria. © 1990, Rockefeller University Press., All rights reserved.
引用
收藏
页码:1083 / 1090
页数:8
相关论文
共 40 条
  • [1] BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
  • [2] AN ATTENUATED AROA SALMONELLA-TYPHIMURIUM VACCINE ELICITS HUMORAL AND CELLULAR-IMMUNITY TO CLONED BETA-GALACTOSIDASE IN MICE
    BROWN, A
    HORMAECHE, CE
    DEHORMAECHE, RD
    WINTHER, M
    DOUGAN, G
    MASKELL, DJ
    STOCKER, BAD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (01) : 86 - 92
  • [3] CHARACTERIZATION OF PLASMODIUM-YOELII MONOCLONAL-ANTIBODIES DIRECTED AGAINST STAGE-SPECIFIC SPOROZOITE ANTIGENS
    CHAROENVIT, Y
    LEEF, MF
    YUAN, LF
    SEDEGAH, M
    BEAUDOIN, RL
    [J]. INFECTION AND IMMUNITY, 1987, 55 (03) : 604 - 608
  • [4] CHEN DH, 1977, J IMMUNOL, V118, P1322
  • [5] IMMUNIZATION OF MAN AGAINST FALCIPARUM AND VIVAX MALARIA BY USE OF ATTENUATED SPOROZOITES
    CLYDE, DF
    MCCARTHY, VC
    MILLER, RM
    WOODWARD, WE
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1975, 24 (03) : 397 - 401
  • [6] NONCHROMOSOMAL ANTIBIOTIC RESISTANCE IN BACTERIA - GENETIC TRANSFORMATION OF ESCHERICHIA-COLI BY R-FACTOR DNA
    COHEN, SN
    CHANG, ACY
    HSU, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1972, 69 (08) : 2110 - &
  • [7] VACCINES AND CELL-MEDIATED-IMMUNITY
    COLLINS, FM
    [J]. BACTERIOLOGICAL REVIEWS, 1974, 38 (04) : 371 - 402
  • [8] DIALYNAS DP, 1983, J IMMUNOL, V131, P2445
  • [9] EFFICACY OF MURINE MALARIA SPOROZOITE VACCINES - IMPLICATIONS FOR HUMAN VACCINE DEVELOPMENT
    EGAN, JE
    WEBER, JL
    BALLOU, WR
    HOLLINGDALE, MR
    MAJARIAN, WR
    GORDON, DM
    MALOY, WL
    HOFFMAN, SL
    WIRTZ, RA
    SCHNEIDER, I
    WOOLLETT, GR
    YOUNG, JF
    HOCKMEYER, WT
    [J]. SCIENCE, 1987, 236 (4800) : 453 - 456
  • [10] TRANSDUCTION OF VIRULENCE WITHIN THE SPECIES SALMONELLA-TYPHIMURIUM
    FURNESS, G
    ROWLEY, D
    [J]. JOURNAL OF GENERAL MICROBIOLOGY, 1956, 15 (01): : 140 - 145